Back to Newsroom

Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology

SAN FRANCISCO, Jan. 22, 2018 ​– Symic Bio, a biopharmaceutical company developing novel matrix-targeting biotherapeutics, today announced the appointment of Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology. With this appointment, Dr. Alaoui will lead research into the identification and characterization of novel therapeutics enabled by the Symic Bio platform.
READ MORE…